# Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head

> **NCT00204542** · PHASE4 · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 418 (actual)

## Conditions studied

- Photosensitivity Disorders

## Interventions

- **DRUG:** Diclofenac
- **DRUG:** Diclofenac

## Key facts

- **NCT ID:** NCT00204542
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2009-03
- **Final completion:** 2010-12
- **Target enrollment:** 418 (ACTUAL)
- **Last updated:** 2011-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00204542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00204542, "Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00204542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*